Daigo Hashimoto

Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 114 publications

Novel therapeutic strategies to separate GVHD from GVL based on GVHD pathophysiology and mechanisms of leukemia relapse

Novel therapeutic strategies to separate GVHD from GVL based on GVHD pathophysiology and mechanisms of leukemia relapse

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: August 03, 2026

A multicenter real-world study of clinical outcomes in octogenarians and older patients with acute myeloid leukemia.

A multicenter real-world study of clinical outcomes in octogenarians and older patients with acute myeloid leukemia.

Journal: Leukemia research

Published: May 04, 2026

Novel approaches for separating graft-versus-leukemia effects from graft-versus-host disease.

Novel approaches for separating graft-versus-leukemia effects from graft-versus-host disease.

Journal: Frontiers in oncology

Published: March 25, 2026

Adverse karyotype amplifies risk in secondary acute myeloid leukemia (AML) and AML with myelodysplasia-related changes.

Adverse karyotype amplifies risk in secondary acute myeloid leukemia (AML) and AML with myelodysplasia-related changes.

Journal: Hematology (Amsterdam, Netherlands)

Published: February 10, 2026

Evaluation of safety, efficacy, and guideline compliance in home-based red blood cell transfusions: An 8.5-year retrospective study in suburban Tokyo.

Evaluation of safety, efficacy, and guideline compliance in home-based red blood cell transfusions: An 8.5-year retrospective study in suburban Tokyo.

Journal: Transfusion medicine (Oxford, England)

Published: November 12, 2025

Recent advances in the pathophysiology of acute and chronic graft-versus-host disease.

Recent advances in the pathophysiology of acute and chronic graft-versus-host disease.

Journal: International journal of hematology

Published: September 30, 2025

Safety and Efficacy of Graft-versus-Host Disease Prophylaxis with Mini-Dose Methotrexate in Umbilical Cord Blood Transplantation: An NJHSG-CBT18 Observational Study.

Safety and Efficacy of Graft-versus-Host Disease Prophylaxis with Mini-Dose Methotrexate in Umbilical Cord Blood Transplantation: An NJHSG-CBT18 Observational Study.

Journal: Transplantation and cellular therapy

Published: August 25, 2025

Early administration of calcineurin inhibitors limits tolerogenic effect of PTCy in allogeneic hematopoietic transplant.

Early administration of calcineurin inhibitors limits tolerogenic effect of PTCy in allogeneic hematopoietic transplant.

Journal: Blood

Published: July 24, 2025

TET3 stirs up trouble via pathogenic Ig class switching.

TET3 stirs up trouble via pathogenic Ig class switching.

Journal: Blood

Published: June 12, 2025

Donor T cell exhaustion and immune tolerance after allogeneic hematopoietic cell transplantation

Donor T cell exhaustion and immune tolerance after allogeneic hematopoietic cell transplantation

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: June 04, 2025

Impact of best response to ibrutinib plus Bendamustine and rituximab on PFS in MCL: a secondary analysis of SHINE.

Impact of best response to ibrutinib plus Bendamustine and rituximab on PFS in MCL: a secondary analysis of SHINE.

Journal: Annals of hematology

Published: April 14, 2025

Early cardiotoxicity in post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis after HLA-haploidentical hematopoietic stem cell transplantation.

Early cardiotoxicity in post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis after HLA-haploidentical hematopoietic stem cell transplantation.

Journal: International journal of hematology

Published: November 25, 2024

Showing 1-12 of 114

Last Updated: 09/26/2026